Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire

Annals of Tropical Medicine and Parasitology

Volumn 101, Issue 2, 2007, Pages 103-112

  Djaman, J A ^a,b   Mazabraud, A ^c   Basco, L ^d  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^b UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d Organisation de Coordination pour la Lutte contre les Endemies en Afrique Centrale Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SENSITIVITY; ENZYME ANALYSIS; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SINGLE DRUG DOSE; TREATMENT FAILURE; TREATMENT OUTCOME; ANIMAL; COTE D'IVOIRE; DRUG COMBINATION; DRUG EFFECT; GENETICS; MALARIA FALCIPARUM; PARASITOLOGY;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; COTE D'IVOIRE; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; HUMANS; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 34548181341     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485907X154584     Document Type: Article

References (27)

1. Basco, L. K., Ramiliarisoa, O. & Le Bras, J. (1994). In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 50, 193-199.
2. Basco, L. K., Eldin de Pécoulas, P., Wilson, C. M., Le Bras, J. & Mazabraud, A. (1995). Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology, 69, 135-138.
3. Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. G. & Hyde, J. E. (1994). Sequence variation of hydroxymethyldihydroprotein pyrophosphokinase: dihydropteroate synthetase gene in lines of the human malaria parasites, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry, 224, 397-405.
4. Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37-46.
5. Desjardins, R. E., Canfields, C. J., Haynes, J. P. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710-718.
6. Djaman, J. A., Basco, L. K. & Mazabraud, A. (2002). Mise en place d'un système de surveillance de la chimiorésistance de Plasmodium falciparum à Yopougon (Abidjan): étude in vivo de la sensibilité à la chloroquine et évaluation de la résistance à la pyrimethamine après analyse de la mutation ponctuelle du gène de la dihydrofolate réductase. Santé, 12, 363-367.
7. Djaman, J. A., Abouanou, S., Basco, L. & Koné, M. (2004a). Limites de l'efficacité de la chloroquine et de la sulfadoxine-pyriméthamine au nord de la ville d'Abidjan (Côte d'Ivoire): étude couplée in vivo/in vitro. Santé, 14, 205-209.
8. Djaman, J. A., Kauffi, P. C., Yavo, W., Basco, L. K. & Koné, M. (2004b). Evaluation in vivo de l'efficacité thérapeutique de l'association sulfadoxine-pyriméthamine au cours du paludisme non compliqué chez les enfants de Yopougon (Abidjan, Côte d'Ivoire). Bulletin de la Société de Pathologie Exotique, 97, 180-182.
9. Dorsey, G., Njama, D., Kamya, M. R., Cattamanchi, A., Kyabayinze, D., Staedke, S. G., Gasasira, A. & Rosenthal, P. J. (2002). Sulfadoxine/ pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet, 360, 2031-2038.
10. Eldin de Pécoulas, P., Basco, L. K., Abdallah, B., Dje, M. K., Le Bras, J. & Mazabraud, A. (1995), Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Experimental Parasitology, 80, 483-487.
11. Fermanian, J. (1984). Mesure de l'accord entre deux juges. Cas qualitatif. Revue Épidémiologique et Santé Publique, 32, 140-147.
12. Foote, S. J., Galatas, D. & Cowman, A. F. (1990). Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the United States of America, 87, 3014-3017.
13. Guiguemde, T. R., Gbary, A. R., Ouedraogo, J. B., Gayibor, A., Lamizana, L., Maiga, A. S., Boureima, H. S., Comlavi, C. E., Faye, O. & Niang, S. O. (1991). Point actuel sur la chimiorésistance du paludisme des sujets autochtones dans les etats de l'OCCGE (Afrique de l'Ouest). Annales de la Société Belge de Médecine Tropicale, 71, 199-207.
14. Henry, M. C., Niangue, J. & Koné, M. (2002). Quel médicament pour traiter le paludisme simple quand la chloroquine devient inefficace dans l'ouest de la Côte d'Ivoire? Médecine Tropicale, 62, 55-57.
15. Hyde, J. E. (1990). The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of maîaria parasites. Pharmacology and Therapeutics, 48, 45-59.
16. Hyde, J. E. (2002). Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes and Infection, 4, 165-174.
17. Kamya, M. R., Dorsey, G., Gasasira, A., Ndeezi, G., Babirye, J. N., Staedke, S. G. & Rosenthal, P. J. (2001). The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 50-55.
18. Masimirembwa, C. M., Phuong Dung, N., Phuc, B. Q., Duc Dao, L., Sy, N. D., Skold, O. & Swedberg, G. (1999). Molecular epidemiology of Plasmodium falciparum antifolate resistance in Vietnam: genotyping for resistance variants of dihydropteroate synthase and dihydrofolate reductase. International Journal of Antimicrobial Agents, 12, 203-211.
19. Mberu, E. K., Nzila, A. M., Nduati, E., Ross, A., Monks, S. M., Kokwaro, G. O., Watkins, W. M. & Sibley, C. (2002). Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Experimental Parasitology, 101, 90-96.
20. Peterson, D. S., Walliker, D. & Wellems, T. E. (1988). Evidence that a point mutation in the dihydrofolate reductase-thymidylate synthase confers resistance to pyrimetharnine in falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 85, 9114-9118.
21. Peterson, D. S., Milhous, W. K. & Wellems, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the United States of America, 87, 3018-3022.
22. Ringwald, P., Keundjian, A., Same Ekobo, A. & Basco, L.K. (2000). Chimiorésistance de P. falciparum en milieu urbain à Yaoundé, Cameroun. Part 2: Evaluation de l'efficacité de l'amodiaquine et de l'association sulfadoxine-pyriméthamine pour le traitement de l'accès palustre simple à Plasmodium falciparum à Yaounde, Cameroun. Tropical Medicine and International Health, 5, 620-627.
23. Triglia, T., Menting, J. G. T., Wilson, C. & Cowman, A. F. (1997). Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America, 94, 13,944-13,949.
24. Wang, P., Lee, C. S., Bayoumi, R., Djimde, A., Dournbo, O., Swedberg, G., Dao, L. D., Mshinda, H., Tanner, M., Watkins, W. M., Sims, P. F. & Hyde, J. E. (1997a). Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Molecular and Biochemical Parasitology, 89, 161-167.
25. Wang, P., Sims, P. F. & Hyde J. E. (1997e). A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance. Parasitology, 115, 223-230.
26. World Health Organization (1996). Assessment of Therapeutic Efficacy for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Document WHO/MAL96.1077. Geneva: WHO.
27. World Health Organization (2003). Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Document WHO/HTM/RBM/2003.50. Geneva: WHO.